Nov 19, 2019
Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues
Nov 18, 2019
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
Nov 18, 2019
Medicenna to Host a Key Opinion Leader Symposium on MDNA55 for Treatment of Recurrent Glioblastoma
Nov 14, 2019
EMulate® Therapeutics Announces Multiple Presentations on the Voyager and Hælo® systems
Nov 14, 2019
Medicenna Announces Presentations on MDNA55 Recurrent Glioblastoma Clinical Trial at the Annual Meeting of the Society of Neuro-Oncology
Nov 13, 2019
Today's New Way to Fight Cancer Focusing on Metabolic Therapies
Nov 12, 2019
Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors
Nov 11, 2019
DNAtrix to Present Updated Results from the Phase 2 CAPTIVE / KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
Nov 08, 2019
Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical's Phase 2 Clinical Trial to be Presented at SITC Annual Meeting
Nov 08, 2019
Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting
Nov 05, 2019
DelMar Pharmaceuticals to Host Key Opinion Leader Summit on Glioblastoma Multiforme and the Potential for Treatment with VAL-083
Oct 22, 2019
BERG Collaboration Identifies Novel Mechanism Of Action Of Redox Regulation By BPM 31510 In Models Of Glioblastoma
Oct 21, 2019
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019
Oct 15, 2019
Denovo Biopharma Receives FDA's Permission to Proceed with a Biomarker-Guided Phase 2b Clinical Trial with DB102 (Enzastaurin) In First-Line Treatment of Glioblastoma (GBM)
Oct 02, 2019
Karolinska University Hospital Announces the First Treatment in the Nordic Region of a Brain Tumor With Laser Ablation
Sep 25, 2019
Medicenna Presents Promising Update from its MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
Sep 13, 2019
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer
Sep 13, 2019
RSSearch® Patient Registry Surpasses 25,000 Patient Cases Using Stereotactic Body Radiotherapy/Stereotactic Radiosurgery
Sep 12, 2019
Medicenna to Present Latest Data from the MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress
Aug 28, 2019
EMulate Therapeutics® Submits Application for CE Mark